Skip to content

Medical emergency? What to do

Experimental drug lowers blood sugar in diabetics

3-RXPublished June 10, 20081 min read

Key points

  • A mid-stage clinical trial of the experimental drug Qnexa showed that it lowered blood sugar and led to weight loss in patients with type 2 diabetes, drug developer Vivus Inc said Tuesday.
  • Participants treated with Qnexa, which is also being developed for obesity, lost 8 percent of their starting body weight, compared with weight loss of 1.2 percent for the placebo group, Vivus said.
  • Vivus said Qnexa patients also had significant improvement in cardiovascular risk factors including blood pressure, triglyceride levels and waist circumference.
  • Vivus said 41 percent of trial patients treated with Qnexa were able to achieve the American Diabetes Association recommended HbAlc goal of 7 percent or lower, versus 26 percent of patients in the placebo group.

A mid-stage clinical trial of the experimental drug Qnexa showed that it lowered blood sugar and led to weight loss in patients with type 2 diabetes, drug developer Vivus Inc said Tuesday.

In the 28-week trial involving 206 subjects, the patients on Qnexa achieved a 1.2 percent reduction in hemoglobin A1c -- a key measure of blood sugar -- compared with a drop of just 0.6 percent for those treated with placebo.

Participants treated with Qnexa, which is also being developed for obesity, lost 8 percent of their starting body weight, compared with weight loss of 1.2 percent for the placebo group, Vivus said.

Qnexa is a combination of phentermine -- part of the notorious "fen-phen" diet pill -- and epilepsy drug Topamax, known generically as topiramate.

Vivus said Qnexa patients also had significant improvement in cardiovascular risk factors including blood pressure, triglyceride levels and waist circumference.

"We are exploring the possibility of proceeding into phase 3 for a diabetes indication," Vivus President and Chief Executive Leland Wilson said in a statement.

Vivus said 41 percent of trial patients treated with Qnexa were able to achieve the American Diabetes Association recommended HbAlc goal of 7 percent or lower, versus 26 percent of patients in the placebo group.

The incidence of hypoglycemia, or low blood sugar, was 6 percent for the Qnexa group and 5 percent for the placebo group.

Side effects were not serious, with the most common ones being nausea, constipation, dry mouth and dizziness, the company said.

LOS ANGELES (Reuters)

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Keep reading

Drug News

Drug shows early promise in treating seizures

A study out today in the journal Nature Medicine suggests a potential new treatment for the seizures that often plague children with genetic metabolic disorders and individuals undergoing liver failure. The discovery…

5 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.